Ruiyi Medical , which was established in May 2016, has independently developed three types of hand rehabilitation robot products, namely “Rui Yi I, II and IIIâ€. Gu Xiangdong, head of Ruiwei Medical Operations, said that clinical practice has proven that the total effective rate of Ruiqi Rehabilitation Robot can reach 80%. It is intuitive that the hand on the sick side of a stroke patient can recover to wash, eat, and other daily actions. In this regard, the author conducted a follow-up report.
Shenzhen Ruiyi Medical Technology Co., Ltd. is a high-end intelligent manufacturing company dedicated to research, development, production and sales of high-tech intelligent rehabilitation robots. The company is deeply involved in the field of stroke rehabilitation robots. It is aimed at the scarcity of products in the field of hand rehabilitation in domestic stroke patients. The three types of hand rehabilitation robot products of "Rui Wei I, II, III" have applied for nearly ten patents including national inventions, utility models and appearances, and some of them have successfully entered dozens of authoritative clinical medical treatments in China. Institutional trial.
Wang Jing, founder of Ruiyi Medical, is an associate professor and doctoral tutor at the School of Mechanical Engineering of Xi'an Jiaotong University. He is a postdoctoral fellow at Georgetown University in the United States. He is a scholar at the Chinese University of Hong Kong and Hong Kong Polytechnic University. He has long been engaged in research in related fields such as rehabilitation robots and brain-computer interfaces. Marketing Director Huang Zhizhi was the director of family business marketing and participated in corporate management for 5 years.
Propaganda Director Gu Xiangdong is a master of film and television art at Communication University of China. He is a senior reporter of CCTV News Channel. He is familiar with the law of media coverage of central media. He has broadcasts resources of CCTV's multiple columns and has participated in CCTV's overall operation and program promotion. CCTV program production and brand promotion experience.
Strong demand, favorable policies, and large resource gaps
According to the statistics of the Health Planning Commission, there are about 12 million patients who are currently living in China (commonly known as “strokeâ€) and are growing at a rate of 2 million a year. As the population ages, the number of surviving stroke patients is expected to reach 32 million by 2030. In addition, according to Gu Xiangdong, when they did market research, they found that due to the high work pressure of middle-aged people, heavy family burden, and insufficient exercise, the risk of stroke in middle-aged people was more concentrated, which led to the trend of younger stroke.
The data show that nearly 50% of stroke patients are 40-64 years old; among those at high risk of stroke, 40-64 years old account for more than 60%. And the recovery willingness and determination of middle-aged stroke patients is significantly higher than that of elderly stroke patients. They exercise 1.5 times a day for older patients.
According to the "Notice on the inclusion of new medical rehabilitation programs in the scope of payment for basic medical insurance" jointly issued by the Ministry of Human Resources and Social Security and the State Health Planning Commission, starting from June 30 this year, the rehabilitation project included in the medical insurance will be 9 The number of items has increased to 29, and medical rehabilitation projects that have been included in the scope of medical insurance payment have been retained. Among them, exercise therapy, hemiplegic limb comprehensive training, and hand function assessment are all included in the scope of medical payment.
Although the demand for rehabilitation medical industry in China is huge, the system is not perfect. The number of rehabilitation departments and rehabilitation specialists in general hospitals in China is 3,800, accounting for 28.4%, the number of rehabilitation beds is 98,992, accounting for 2.2%, and the number of rehabilitation medical personnel is 39,833. %, no systematic, complete and sufficient rehabilitation medical supply system has been formed. In addition, there is a lack of uniform industry management standards; rehabilitation institutions are small in scale, low in grade, small in number, and the level of construction needs to be improved.
In the rehabilitation medical market, the upper and lower limb rehabilitation robot products are mature, and the manufacturers include Swiss Lokomat, Israel Rewalk & MediTouch, Anyang Shenfang and so on. However, hand rehabilitation products are scarce. At present, the products on the domestic market include Guangzhou Yikang A5 and Hong Kong Rehab Robotics Hand of Hope. Guangzhou Yikang A5 is developed by real-time simulation of human finger and wrist movement rules. It has the function of finger flexor muscle strength signal and extensor muscle strength signal evaluation. At the same time, it can train hands and train wrists. The price is 50- 600000. Hong Kong RehabRobotics Hand of hope is a product of Hong Kong Trust Group, which is priced at RMB 800,000-900,000. Both products are more expensive.
In addition, most stroke patients rely on traditional methods such as massage acupuncture for rehabilitation, but this method is basically ineffective for patients with stroke for more than half a year. Because the hand is a terminal nerve rehabilitation, it is particularly difficult to recover.
In this context, Shenzhen Ruiyi Medical was established, and the company's products gradually came out.
Ultraviolet Absorbent&Photoinitiators
Specialized in R&D,manufacturing of Ultraviolet absorbent,photoinitiators , Colorfomers and sensitives of carbonless and therm paper.
Ultraviolet Absorbent,Ultraviolet Photoinitiators,Colorfomers,Sensitives of Carbonless and Therm Paper
Taizhou Volsen Chemical Co., Ltd. , https://www.volsenchem.com